Checkpoint Trends submits board meeting intimation

16 May 2024 Evaluate
Checkpoint Trends has informed that the Meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 25, 2024, to take on record the following: To adopt the Standalone Audited Financial Results along with asset and liability statement and cash flow statement of the Company for the quarter and year ended March 31, 2024; To adopt Related Party Transaction pursuant to regulation 23(9) of SEBI (LODR) 2015 for the year ended March 31, 2025; Cessation of Sunil Khandalwal as Managing Director of the Company due to expiry of term and not opting for reappointment; Reappointment of Gopal Kumar Sahu as Independent Director of the Company for a period of 5 years. The Company shall intimate to the exchange the Standalone Audited Financial Results upon the conclusion of the Board Meeting as required by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, vide letter dated March 28, 2024, they had intimated that the Trading Window for dealing in securities of the Company, shall remain closed for all the Designated Persons and their immediate relatives covered under Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct), from Monday, April 1, 2024 till 48 hours after the announcement of Audited Financial Results of the Company for the quarter and year ended March 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Rubra Medicaments Share Price

8.89 -0.46 (-4.92%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Redington 198.55
Adani Enterprises 3411.45
Amrapali Industries 14.50
Rashi Peripheral 305.00
Compuage Infocom 3.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.